Testing effectiveness (Phase 2)Ended earlyNCT02488694
What this trial is testing
Maintaining ERBB Blockade in EGFR-mutated Lung Cancer
Who this might be right for
Non-small-cell Lung Cancer With Somatic EGFR Mutations
AIO-Studien-gGmbH 4
Showing 5 of 5 results